← Back to home
Comparison · Analytics

DoseFinding vs ReLTER

A side-by-side editorial comparison of DoseFinding and ReLTER — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs ReLTER: at a glance

FeatureDoseFindingReLTER
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingecology, research-infrastructure, ropensci, environmental-data
Last editorial update1h ago4h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is ReLTER?

An interface to Europe's long-term ecosystem research network that went quiet after 2.0.

ReLTER provides programmatic access to the eLTER network — the European long-term ecosystem research infrastructure — pulling site metadata, datasets and activities from DEIMS-SDR and enriching them with taxonomic resolution via PESI and WORMS and raster layers from European OpenDataScience. Version 1.0.0 consolidated the function surface and passed into rOpenSci review; 1.1.0 addressed the reviewers' feedback and added vignettes and a Docker install path. Version 2.0.0 was tagged in late 2022 with release notes consisting only of a merge commit message, and nothing has shipped since.

Read the full ReLTER trajectory →

DoseFinding vs ReLTER: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

R
ReLTER
ANALYTICS
0.0

An interface to Europe's long-term ecosystem research network that went quiet after 2.0.

◆ Current state

ReLTER provides programmatic access to the eLTER network — the European long-term ecosystem research infrastructure — pulling site metadata, datasets and activities from DEIMS-SDR and enriching them with taxonomic resolution via PESI and WORMS and raster layers from European OpenDataScience. Version 1.0.0 consolidated the function surface and passed into rOpenSci review; 1.1.0 addressed the reviewers' feedback and added vignettes and a Docker install path. Version 2.0.0 was tagged in late 2022 with release notes consisting only of a merge commit message, and nothing has shipped since.

◆ Where it's heading

The visible arc runs from a scattered set of getSite* functions to a reviewed, documented package, and then stops. The absence of notes on the 2.0.0 tag makes it impossible to say from this feed what that major version changed, and the three-year silence afterwards is the more informative signal. What the package does remains useful — the eLTER data it wraps has no other R interface — but the release history gives no evidence of active development.

◆ Prediction

Nothing in these entries supports a confident prediction about future releases; the feed shows a major version with no notes followed by silence. Whether the package is dormant or simply publishing releases elsewhere cannot be determined from what is here.

Alternatives to DoseFinding and ReLTER

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or ReLTER.

See all DoseFinding alternatives → · See all ReLTER alternatives →

Recent activity from DoseFinding and ReLTER

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1y agoDoseFindingConditional and predictive power for interim analyses
  2. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  3. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  4. 2y agoDoseFindingCompliance update for R-devel
  5. 3y agoDoseFindingpowMCTBinCount bug fix
  6. 3y agoReLTERReLTER an Interface for the 'eLTER' Community v2.0.0
  7. 4y agoReLTERReLTER v1.1.0
  8. 4y agoReLTERReLTER v1.0.0

Frequently asked questions

What is the difference between DoseFinding and ReLTER?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and ReLTER are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than ReLTER?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and ReLTER are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to ReLTER?

Top ReLTER alternatives in Analytics are ranked by recent ship velocity. Browse the "ReLTER alternatives" section above for the current picks, or visit /alternatives/relter for the full list with editorial commentary on each.